Your session is about to expire
← Back to Search
Hemopure for Anemia
Study Summary
This trial will allow people with life-threatening anemia to be treated with HBOC-201, which is not FDA approved in the US, but is approved as an oxygen carrier in South Africa and Russia.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You need to receive blood transfusions.You are allergic to beef products.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible for me to register as a participant in this trial?
"This medical trial seeks 50 anemic individuals aged 18 to 80. In order for potential participants to be eligible, their hemoglobin levels must be 8g/dL or below and they need to exhibit symptoms of ischemia that include altered mental states, acute renal failure, lactic acidosis, or central nervous system supply dependency. Moreover, legitimate consent forms must be signed by the patient or a legally appointed representative."
Does this research endeavor currently admit new participants?
"This clinical trial, which was initially declared on October 1st 2013 and was last modified on August 16th 2021, does not currently require any additional participants. However, there are 222 other trials that do need volunteers at this time."
Is enrollment in this trial restricted to adults?
"This medical study requires willing participants to be 18 years old or over, and not exceed 80 years in age."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger